June 2026 in “Homo Politicus (Academy of Humanities and Economics in Lodz)” The effectiveness of ingredients in anti-hair loss products varies, and clinical trials are crucial to determine their success.
June 2026 in “International Journal of Drug Delivery Technology” In this study using fertilized chicken eggs, researchers reported that ethanol and aqueous extracts of clove, cinnamon, and coriander significantly reduced blood vessel formation, indicating these herbs' potential as safe anti-angiogenic treatments without severe side effects compared to synthetic drugs.
June 2026 in “Clinical and Experimental Dermatology” This correspondence discusses interpretative challenges in a recent study on fibrosing alopecia, highlighting that observed disease stabilization may not imply lasting control due to diagnostic inconsistencies.
June 2026 in “Clay Minerals” In this review, researchers highlighted the potential of clay minerals like kaolinite and zeolite as promising haemostatic materials, due to properties such as high water absorption and good biocompatibility, while discussing their current advances and the importance of integrating multifunctional capabilities for future wound dressings.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers developed a hybrid deep learning model called ScalpViT that accurately diagnosed scalp diseases with 94.3% accuracy, surpassing existing methods like ResNet-50 and EfficientNet-B3, and providing visual explainability for clinicians using GradCAM and Attention Rollout techniques.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study introduces ScalpViT, a new deep learning model that accurately diagnoses visually similar scalp diseases with 94.3% accuracy, outperforming other methods like ResNet-50 and EfficientNet-B3, and providing dual visual explainability through GradCAM and Attention Rollout, potentially benefiting diagnosis in resource-limited settings in India.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers developed ScalpViT, a novel deep learning model, to improve the automated diagnosis of visually similar scalp diseases, achieving 94.3% accuracy and outperforming existing models like ResNet-50 and EfficientNet-B3 when tested on a diverse dataset of 7,000 images.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, Clitoria ternatea (Sangu Poo) was noted for its potential roles in health and skincare, with lab tests showing antioxidant, antimicrobial, liver-protective, and cancer-related activities; however, human trial evidence is lacking, impacting consistent quality and progress.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study reviews the traditional and emerging medicinal uses of Clitoria ternatea Linn., highlighting its extensive chemical composition and potential health benefits, but notes the lack of human trial evidence and the need for better testing methods to ensure consistent quality and efficacy.
June 2026 in “Journal of Cosmetic Dermatology” This review highlights that combination pharmacotherapy for androgenetic alopecia may offer enhanced hair growth efficacy and reduced side effects through distinct mechanisms, allowing for personalized treatment regimens that improve patient compliance and therapeutic outcomes.
June 2026 in “International Journal of Women’s Dermatology” This review highlights significant knowledge gaps in the safety of alopecia treatments during pregnancy, IVF, and PCOS contexts, noting that many medications lack robust safety data, and underscores the need for more targeted research to guide treatment decisions.
June 2026 in “Value in Health” The measures for eyebrow and eyelash hair loss in severe Alopecia Areata are reliable and useful for clinical trials.
May 2026 in “International Journal of Pharmaceutical Quality Assurance” This study reported that among 95 women with polycystic ovarian syndrome at a tertiary care hospital in India, menstrual irregularities were the most common issue, affecting 86.3% of participants, with many also experiencing hyperandrogenic symptoms, obesity, and infertility.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study highlights Clitoria ternatea's potential in modern health and skincare, noting its antioxidant, antimicrobial, and anti-inflammatory properties observed in lab tests and exploring its uses in beauty products, yet emphasizes the need for human trials to confirm benefits and ensure quality.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, Clitoria ternatea Linn., a plant from the pea family, is noted for potential health benefits, including antioxidant, antimicrobial, and anti-inflammatory effects, though human trial evidence is lacking and research on consistent quality is needed for practical applications.
May 2026 in “Research Square” In this study of women aged 18-45 from an endocrine referral group, researchers found that while clinical hirsutism severity is independently associated with biochemical hyperandrogenism, the relationship is modest and suggests different biological aspects are at play.
May 2026 in “Global Translational Medicine” This study found that ethanol extract of Syzygium aromaticum (clove) leaves significantly improved lipid profiles and increased body weight in testosterone-induced benign prostatic hyperplasia rats, suggesting potential anti-hyperlipidemic effects and modulation of body weight through metabolic activity.
May 2026 in “International Journal of Technology in Education and Science” This study developed a leakage-resistant machine learning framework for classifying hair loss types, emphasizing transparency through explainable AI. Among tested models, Extreme Gradient Boosting excelled, achieving high accuracy and stability on both cross-validation and holdout datasets.
This study found clinical markers like leukotrichia and trichrome lesions in non-segmental vitiligo patients were linked to greater disease extent and poor response to treatment.
May 2026 in “Clinical Cosmetic and Investigational Dermatology” This study found that while both buffy coat and apheresis PRP improved androgenetic alopecia, the buffy coat method was linked to greater patient-reported improvement despite having lower platelet counts.
May 2026 in “International Journal of Homoeopathic Sciences” In this case report, long-term classical homeopathic management of a woman with advanced female pattern baldness led to significant hair stabilization, improved scalp health, increased hair density, and notable psychosocial benefits, despite previous treatment failures.
May 2026 in “International Journal of Homoeopathic Sciences” This case study reported that individualized classical homeopathic treatment, combined with aesthetic therapy, led to significant and sustained improvement in androgenetic alopecia for a young male patient over 30 months.
May 2026 in “Clinical Cosmetic and Investigational Dermatology” This study observed that white hair can create an optical illusion of increased scalp visibility, potentially misleading clinical evaluations of hair loss and complicating hair transplantation planning, and identified five core dyeing strategies to address this phenomenon.
May 2026 in “IOSR Journal of Dental and Medical Sciences” This study evaluated the use of automated microneedling therapy for managing facial scars, finding significant improvement in scar size and vascularity with minimal complications, particularly between the second and third treatment sessions, and achieving good to excellent patient satisfaction in two-thirds of participants.
May 2026 in “International Journal of Homoeopathic Sciences” In this case report, a 25-year-old male with alopecia universalis showed sustained hair regrowth and psychological improvements over 21 months following individualized homeopathic treatment, despite prior failures with conventional therapies, as observed at Dr Batra’s® Homeopathy Clinic.
April 2026 in “Almanac of Clinical Medicine” In this study, pemphigus vulgaris patients treated with high-dose prednisolone developed symptoms similar to those seen in corticosteroma, such as weight gain and muscle weakness, with increased risks of arterial hypertension and glucose metabolism disorders after 6 months of therapy.
April 2026 in “Journal of Aesthetic Medicine” This study found that the MIRA technique, using ultrasound-guided needle adjustments, improved cellulite treatment outcomes compared to standard methods in women with stage 3 cellulite, evidenced by greater reductions in adipose thickness and other skin irregularities, along with higher patient satisfaction.
April 2026 in “International Journal of Drug Delivery Technology” This review highlights the various causes and treatment options for alopecia, noting that while non-scarring types often see successful hair regrowth, scarring forms require early intervention to manage inflammatory destruction of hair follicles.
April 2026 in “Dermatology and Therapy” This Delphi consensus study provides expert insights into hair aging, aims to enhance diagnostic precision and management of age-related hair changes, and identifies possible new therapeutic targets.
April 2026 in “SHILAP Revista de lepidopterología” This study reviews the therapeutic applications and evidence around punch-based dermatologic techniques, highlighting their varying effectiveness and precision across different conditions, but emphasizes the need for further standardized research.